TrialBritish journal of cancer2005

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.

M Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.